Dr. Patrick Kevin Reville, MD

Dr. Reville practices at Norwalk Hospital in Norwalk, Connecticut.

Dr. Reville's NPI, 1619404530, was assigned on May 23, 2017. Dr. Reville graduated from University of Wisconsin School of Medicine in 2017. Dr. Reville holds Texas license BP10060366.

Dr. Reville's primary practice is Norwalk Hospital, at 34 Maple St, Norwalk, CT 06850 in Western Ct County. The practice phone is (203) 852-2216.

Dr. Reville's primary practice is Norwalk Hospital in Norwalk, Connecticut. Dr. Reville is also affiliated with Norwalk Hospital. The medical group on file is Danbury Medical Group. Dmand AI also links Dr. Reville to 1 more hospital and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Reville practices, 3 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Reville's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Reville is licensed in Texas.

CMS data shows 215 Medicare services from Dr. Reville across 4 procedure codes in 2024, for 78 Medicare patients. Medicare paid $13,679 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 78 Medicare patients who saw Dr. Reville in 2024. The largest group is 75 to 84, with 39 patients. 75% of them have high blood pressure, and 72% have high cholesterol. Their average risk score is 3.03, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Reville's median patient age at 73, with 51% women.

In 2024, Dr. Reville wrote 142 Medicare Part D claims for 30 patients. 77% of them were for generic drugs. CMS names the drug for 46 of them, across 3 drugs with 11 or more claims each, at $7,751 in total drug cost. In 2023, CMS named 14 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Reville for performance year 2024, reported as part of a group. Dr. Reville accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 6 general payments to Dr. Reville from 5 drug and device companies from 2018 to 2025. Food and beverage make up the largest share, 100% of the total. ADC Therapeutics America, Inc. paid the most, $150.

Dr. Reville graduated from University of Wisconsin School of Medicine in 2017.